Mouse Hybridoma Clone 3D12 Against Human HLA-E (3D12 Hybridoma, TID 00544)

Researchers at Fred Hutchinson Cancer Center have developed a new hybridoma cell line that expresses mouse anti-human HLA-E antibodies.

Reference:

  • Geraghty et al., J. Immunol. 1998; 1604651-4960 “HLA-E Surface Expression Depends on Binding of TAP-Dependent Peptides Derived from Certain HLA Class I Signal Sequences”

Available Licenses

To license this product, please complete, sign and return the license agreement to bds@fredhutch.org. Further instructions are provided therein.

Please Note: Academic and non-profit users may license the material for free. Fees for for-profit users are listed in the license agreements. All recipients must pay a fee for material preparation and shipping expenses.

Download license agreement
Commerical Use | Non-commerical Use

Credit Line for Acknowledgement

When publishing on the use of this material, please provide credit to Dr. Daniel Geraghty according to accepted publications standards.

Questions About this Product?

Contact the Business Development team